Efficacy of rituximab in patients with Graves’ orbitopathy: a retrospective multicenter nationwide study

被引：0
|
作者：
Jean-Baptiste Deltour
Marie d’Assigny Flamen
Miriam Ladsous
Lama Giovansili
Bertrand Cariou
Philippe Caron
Delphine Drui
Pierre Lebranchu
机构：
[1] CHU Nantes,Department of Ophthalmology, Hotel Dieu
[2] CHU Nantes,Department of Endocrinology Diabetes and Nutrition, L’institut du thorax
[3] Department of Endocrinology CHRU Lille,Department of Internal Medicine, Section of Endocrinology
[4] Fondation Ophtalmologique A de Rothschild,Department of Endocrinology, Metabolic Diseases and Nutrition, Pôle Cardio
[5] CHU Toulouse,Vasculaire et Métabolique
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2020年 / 258卷
关键词：
Rituximab; Anti-CD20 antibody; Graves’ orbitopathy; Basedow’s disease; Clinical activity score (CAS);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2013 / 2021
页数：8
相关论文
共 50 条
  • [31] A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves’ orbitopathy
    Kristian T. M. Johnson
    Andrea Wittig
    Christian Loesch
    Joachim Esser
    Werner Sauerwein
    Anja K. Eckstein
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 103 - 109
  • [32] A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathy
    Johnson, Kristian T. M.
    Wittig, Andrea
    Loesch, Christian
    Esser, Joachim
    Sauerwein, Werner
    Eckstein, Anja K.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (01) : 103 - 109
  • [33] Statin Use and the Risk of Graves' Orbitopathy: A Nationwide Population-Based Cohort Study
    Chou, Yu-Tsung
    Lai, Chun-Chieh
    Li, Chung-Yi
    Shen, Wei-Chen
    Huang, Yu-Tung
    Wu, Yi-Lin
    Lin, Yi-Hsuan
    Yang, Deng-Chi
    Yang, Yi-Ching
    THYROID, 2025, 35 (02) : 199 - 207
  • [34] Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves' Orbitopathy
    Campi, Irene
    Vannucchi, Guia
    Muller, Ilaria
    Lazzaroni, Elisa
    Curro, Nicola
    Dainese, Martina
    Montacchini, Benedetta
    Covelli, Danila
    Guastella, Claudio
    Pignataro, Lorenzo
    Fugazzola, Laura
    Arosio, Maura
    Salvi, Mario
    FRONTIERS IN ENDOCRINOLOGY, 2022, 12
  • [35] SAFETY AND EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH CANCER AND PREEXISTING AUTOIMMUNE DISEASES: A NATIONWIDE MULTICENTER RETROSPECTIVE STUDY
    Tison, A.
    Quere, G.
    Misery, L.
    Funck-Brentano, E.
    Danlos, F. -X.
    Bonniaud, B.
    Scalbert, C.
    Lesimple, T.
    Martinez, S.
    Marcq, M.
    Chouaid, C.
    Dubos, C.
    Brunet-Possenti, F.
    Stavris, C.
    Chiche, L. Y.
    Cornec, D.
    Kostine, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 147 - 147
  • [36] Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy by Vannucchi (vol 31, pg 821, 2021)
    Vannucchi, Guia
    Campi, Irene
    Covelli, Danila
    Curro, Nicola
    Lazzaroni, Elisa
    Palomba, Andrea
    Soranna, Davide
    Zambon, Antonella
    Fugazzola, Laura
    Muller, Ilaria
    Guastella, Claudio
    THYROID, 2022, 32 (05) : 605 - 605
  • [37] Facial expression of patients with Graves' orbitopathy
    Lei, C.
    Qu, M.
    Sun, H.
    Huang, J.
    Huang, J.
    Song, X.
    Zhai, G.
    Zhou, H.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2023, 46 (10) : 2055 - 2066
  • [38] Concurrent Myopathy in Patients with Graves' Orbitopathy
    Mensink, Hanneke W.
    van Doorn, Pieter A.
    Paridaens, Dion
    ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY, 2009, 28 (01): : 66 - 70
  • [39] Low dose of rituximab: a novel therapy option for the treatment of Graves' orbitopathy
    Ulmann, G.
    Cransac, A.
    Baylatry, M. -T.
    Riviere, S.
    Berche, M.
    Du Pasquier, L.
    Joly, A. -C.
    Heron, E.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1251 - 1251
  • [40] Therapeutic innovations in endocrine diseases - Part 5: Rituximab and graves' orbitopathy
    Ladsous, Miriam
    PRESSE MEDICALE, 2016, 45 (06): : E221 - E224
12345